Showing results (211-220 of 1,027) with videos related to
Sort By:
Pageof 103
Oncology Research and Treatment|April 16, 2014
Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastomaKatharina Seystahl, Michael Weller, Oliver Bozinov, et al.European Journal of Cancer (Oxford, England : 1990)|June 17, 2019
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trialsMarijke Coomans, Linda Dirven, Neil K Aaronson, et al.Neuro-Oncology|April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival periodMarijke B Coomans, Linda Dirven, Neil Aaronson, et al.The New England Journal of Medicine|March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaRoger Stupp, Warren P Mason, Martin J van den Bent, et al.Biochemical Pharmacology|September 25, 2003
Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast)Michael Platten, Katrin Eitel, Jörg Wischhusen, et al.International Journal of Cancer|October 12, 2005
Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivoSteffen Aulwurm, Jörg Wischhusen, Manuel Friese, et al.Swiss Medical Weekly|January 9, 2013
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010Andreas Maercker, Axel Perkonigg, Martin Preisig, et al.Acta Neuropathologica|May 22, 2013
Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approachMarkus J Riemenschneider, David N Louis, Michael Weller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant gliomaMichael Weller, Bettina Müller, Rainer Koch, et al.Acta Neuropathologica|August 9, 2003
PTEN methylation and expression in glioblastomasNathalie Baeza, Michael Weller, Yasuhiro Yonekawa, et al.Pageof 103